# Tuberculosis Drug Levels and Continuous Glucose Monitoring in Diabetic Patients

> **NCT05329415** · — · UNKNOWN · sponsor: **London North West Healthcare NHS Trust** · enrollment: 48 (estimated)

## Conditions studied

- Tuberculosis
- Diabetes Mellitus

## Interventions

- **DIAGNOSTIC_TEST:** TB Drug Levels

## Key facts

- **NCT ID:** NCT05329415
- **Lead sponsor:** London North West Healthcare NHS Trust
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-02-01
- **Primary completion:** 2023-05-01
- **Final completion:** 2024-05
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2023-06-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05329415

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05329415, "Tuberculosis Drug Levels and Continuous Glucose Monitoring in Diabetic Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05329415. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*